Enzene, a global development and manufacturing organization based in India, has expanded its global biotech capabilities in the U.S. with the opening of a state-of-the-art biomanufacturing facility in Hopewell, NJ. The new 80,000-sq.-ft. facility represents Enzene’s first major manufacturing investment in the U.S. to support pharmaceutical innovation and supply chain resilience across North America.  In addition to fed-batch drug substance manufacturing, the site leverages the company’s modul...